Gainers
- NexImmune NEXI stock increased by 64.6% to $0.67 during Thursday's pre-market session. The market value of their outstanding shares is at $17.6 million.
- Axcella Health AXLA shares rose 34.25% to $0.81. The company's market cap stands at $59.5 million.
- Biotricity BTCY shares moved upwards by 23.52% to $0.84. The market value of their outstanding shares is at $44.1 million. As per the news, the Q3 earnings report came out 2 days ago.
- Emergent BioSolutions EBS stock increased by 19.9% to $17.89. The market value of their outstanding shares is at $892.5 million.
- Inozyme Pharma INZY shares increased by 19.81% to $2.66. The company's market cap stands at $107.4 million.
- Talaris Therapeutics TALS stock rose 13.92% to $1.8. The market value of their outstanding shares is at $75.1 million.
Losers
- TransCode Therapeutics RNAZ shares decreased by 20.9% to $0.53 during Thursday's pre-market session. The company's market cap stands at $6.8 million.
- Tenon Medical TNON stock declined by 8.72% to $1.99. The market value of their outstanding shares is at $22.3 million.
- Sera Prognostics SERA shares fell 7.49% to $2.1. The company's market cap stands at $65.1 million.
- Healthcare Triangle HCTI stock fell 7.17% to $0.28. The company's market cap stands at $11.5 million.
- Invivyd IVVD shares declined by 7.11% to $1.83. The market value of their outstanding shares is at $199.4 million.
- Hyperfine HYPR shares decreased by 6.58% to $1.42. The company's market cap stands at $100.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
EBSEmergent BioSolutions Inc
$8.403.07%
HCTIHealthcare Triangle Inc
$0.78772.03%
INZYInozyme Pharma Inc
$2.99-0.66%
IVVDInvivyd Inc
$0.520010.4%
NEXINexImmune Inc
$0.331018.6%
RNAZTransCode Therapeutics Inc
$3.51-1.86%
SERASera Prognostics Inc
$8.36-2.79%
TNONTenon Medical Inc
$1.782.30%
HYPRHyperfine Inc
$0.8601-0.37%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in